We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,919
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCOR icon
7201
Core Alternative Capital
CCOR
$27.8M
$7K ﹤0.01%
254
-456
-64% -$12.4K
CHNR icon
7202
China Natural Resources
CHNR
$4.55M
$7K ﹤0.01%
110
+39
+55% +$2.71K
COHN icon
7203
Cohen & Co
COHN
$33.3M
$7K ﹤0.01%
1,545
-402
-21% -$2.28K
CPHI icon
7204
China Pharma Holdings
CPHI
$45M
$7K ﹤0.01%
42
+36
+600% +$5.78K
CRIS icon
7205
Curis
CRIS
$9.78M
$7K ﹤0.01%
9
-11
-55% -$7.71K
DOGZ icon
7206
Dogness International Corp
DOGZ
$12.8M
$7K ﹤0.01%
126
+79
+168% +$5.04K
DRRX
7207
DELISTED
DURECT Corp
DRRX
$7K ﹤0.01%
1,030
+12
+1% +$75
EDSA icon
7208
Edesa Biotech
EDSA
$49.2M
$7K ﹤0.01%
138
+75
+119% +$3.3K
FXP icon
7209
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$5.64M
$7K ﹤0.01%
61
-275
-82% -$34.4K
GRVY
7210
GRAVITY
GRVY
$430M
$7K ﹤0.01%
149
-997
-87% -$67.9K
HHS icon
7211
Harte-Hanks
HHS
$16.2M
$7K ﹤0.01%
3,167
-259
-8% -$822
KF
7212
Korea Fund
KF
$231M
$7K ﹤0.01%
246
LMFA
7213
DELISTED
LM Funding America
LMFA
$7K ﹤0.01%
+8
New +$7.89K
MMIN icon
7214
IQ MacKay Municipal Insured ETF
MMIN
$463M
$7K ﹤0.01%
279
+278
+27,800% +$7.16K
NGNE icon
7215
Neurogene
NGNE
$656M
$7K ﹤0.01%
+143
New +$7.35K
NTIC icon
7216
Northern Technologies International Corp
NTIC
$76.2M
$7K ﹤0.01%
1,122
-1,326
-54% -$16.8K
ORMP icon
7217
Oramed Pharmaceuticals
ORMP
$167M
$7K ﹤0.01%
1,923
+693
+56% +$2.45K
PALI icon
7218
Palisade Bio
PALI
$330M
0
PETZ icon
7219
TDH Holdings
PETZ
$12.2M
$7K ﹤0.01%
480
+366
+321% +$5.69K
PRSO icon
7220
Peraso
PRSO
$9.78M
$7K ﹤0.01%
48
+8
+20% +$1.29K
PXS icon
7221
Pyxis Tankers
PXS
$48.7M
$7K ﹤0.01%
1,633
+521
+47% +$2.44K
QNRX
7222
Quoin Pharmaceuticals
QNRX
$8.94M
0
RCON icon
7223
Recon Technology
RCON
$39.7M
$7K ﹤0.01%
105
+49
+88% +$3.97K
SXTC icon
7224
China SXT Pharmaceuticals
SXTC
$2.36M
0
TACT icon
7225
Transact Technologies
TACT
$53.2M
$7K ﹤0.01%
608

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.